Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack-Reference-Cited by-同舟云学术

Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack

Author:

Henderson David¹,Ogilvie Lesley A.²³,Hoyle Nicholas⁴,Keilholz Ulrich⁵,Lange Bodo³,Lehrach Hans²³⁶,OncoTrack Consortium

Affiliation:

1. Bayer Pharma AG, Berlin, Germany

2. Max Planck Institute for Molecular Genetics, Berlin, Germany

3. Alacris Theranostics, GmbH, Berlin, Germany

4. Roche Diagnostics GmbH, Penzburg, Germany

5. Charité Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany

6. Dahlem Centre for Genome Research and Medical Systems Biology, Berlin, Germany

Funder

Innovative Medicines Initiative Joint Undertaking

European Union's Seventh Framework Programme

EFPIA companies

Funded Access

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

Link

Reference91 articles.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献